Logo image of IBM

INTL BUSINESS MACHINES CORP (IBM) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:IBM - US4592001014 - Common Stock

301.89 USD
+6.92 (+2.35%)
Last: 1/6/2026, 3:24:09 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to IBM. IBM was compared to 88 industry peers in the IT Services industry. While IBM belongs to the best of the industry regarding profitability, there are concerns on its financial health. IBM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

IBM had positive earnings in the past year.
IBM had a positive operating cash flow in the past year.
IBM had positive earnings in each of the past 5 years.
IBM had a positive operating cash flow in each of the past 5 years.
IBM Yearly Net Income VS EBIT VS OCF VS FCFIBM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

IBM's Return On Assets of 5.40% is fine compared to the rest of the industry. IBM outperforms 69.32% of its industry peers.
IBM has a better Return On Equity (28.34%) than 89.77% of its industry peers.
IBM's Return On Invested Capital of 8.07% is fine compared to the rest of the industry. IBM outperforms 70.45% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IBM is significantly below the industry average of 28.99%.
The last Return On Invested Capital (8.07%) for IBM is above the 3 year average (7.07%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.4%
ROE 28.34%
ROIC 8.07%
ROA(3y)3.74%
ROA(5y)3.83%
ROE(3y)20.94%
ROE(5y)24.07%
ROIC(3y)7.07%
ROIC(5y)6.14%
IBM Yearly ROA, ROE, ROICIBM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

IBM has a Profit Margin of 12.09%. This is amongst the best in the industry. IBM outperforms 84.09% of its industry peers.
IBM's Profit Margin has declined in the last couple of years.
IBM's Operating Margin of 16.06% is amongst the best of the industry. IBM outperforms 84.09% of its industry peers.
IBM's Operating Margin has been stable in the last couple of years.
IBM's Gross Margin of 57.81% is fine compared to the rest of the industry. IBM outperforms 79.55% of its industry peers.
IBM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.06%
PM (TTM) 12.09%
GM 57.81%
OM growth 3Y10.6%
OM growth 5Y0.28%
PM growth 3Y-1.4%
PM growth 5Y-10.1%
GM growth 3Y1.05%
GM growth 5Y0.73%
IBM Yearly Profit, Operating, Gross MarginsIBM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBM is destroying value.
The number of shares outstanding for IBM has been increased compared to 1 year ago.
Compared to 5 years ago, IBM has more shares outstanding
IBM has a better debt/assets ratio than last year.
IBM Yearly Shares OutstandingIBM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
IBM Yearly Total Debt VS Total AssetsIBM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

An Altman-Z score of 3.51 indicates that IBM is not in any danger for bankruptcy at the moment.
IBM's Altman-Z score of 3.51 is fine compared to the rest of the industry. IBM outperforms 60.23% of its industry peers.
IBM has a debt to FCF ratio of 5.27. This is a neutral value as IBM would need 5.27 years to pay back of all of its debts.
With a Debt to FCF ratio value of 5.27, IBM perfoms like the industry average, outperforming 53.41% of the companies in the same industry.
IBM has a Debt/Equity ratio of 1.98. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of IBM (1.98) is worse than 73.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.98
Debt/FCF 5.27
Altman-Z 3.51
ROIC/WACC0.91
WACC8.83%
IBM Yearly LT Debt VS Equity VS FCFIBM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 0.93 indicates that IBM may have some problems paying its short term obligations.
IBM has a Current ratio of 0.93. This is in the lower half of the industry: IBM underperforms 79.55% of its industry peers.
IBM has a Quick Ratio of 0.93. This is a bad value and indicates that IBM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.89, IBM is doing worse than 80.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.89
IBM Yearly Current Assets VS Current LiabilitesIBM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

IBM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.71%.
Measured over the past years, IBM shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.21% on average per year.
Looking at the last year, IBM shows a small growth in Revenue. The Revenue has grown by 4.51% in the last year.
Measured over the past years, IBM shows a small growth in Revenue. The Revenue has been growing by 1.69% on average per year.
EPS 1Y (TTM)6.71%
EPS 3Y1.19%
EPS 5Y-4.21%
EPS Q2Q%15.22%
Revenue 1Y (TTM)4.51%
Revenue growth 3Y3.05%
Revenue growth 5Y1.69%
Sales Q2Q%9.11%

3.2 Future

IBM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.07% yearly.
Based on estimates for the next years, IBM will show a small growth in Revenue. The Revenue will grow by 5.12% on average per year.
EPS Next Y11.1%
EPS Next 2Y9.19%
EPS Next 3Y8.11%
EPS Next 5Y6.07%
Revenue Next Year6.83%
Revenue Next 2Y5.7%
Revenue Next 3Y5.23%
Revenue Next 5Y5.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IBM Yearly Revenue VS EstimatesIBM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20B 40B 60B 80B
IBM Yearly EPS VS EstimatesIBM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

IBM is valuated quite expensively with a Price/Earnings ratio of 27.52.
IBM's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.87. IBM is around the same levels.
IBM is valuated rather expensively with a Price/Forward Earnings ratio of 24.51.
The rest of the industry has a similar Price/Forward Earnings ratio as IBM.
When comparing the Price/Forward Earnings ratio of IBM to the average of the S&P500 Index (23.46), we can say IBM is valued inline with the index average.
Industry RankSector Rank
PE 27.52
Fwd PE 24.51
IBM Price Earnings VS Forward Price EarningsIBM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as IBM.
IBM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 23.57
EV/EBITDA 20.9
IBM Per share dataIBM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of IBM may justify a higher PE ratio.
PEG (NY)2.48
PEG (5Y)N/A
EPS Next 2Y9.19%
EPS Next 3Y8.11%

5

5. Dividend

5.1 Amount

IBM has a Yearly Dividend Yield of 2.27%. Purely for dividend investing, there may be better candidates out there.
IBM's Dividend Yield is rather good when compared to the industry average which is at 0.44. IBM pays more dividend than 92.05% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, IBM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.27%

5.2 History

The dividend of IBM has a limited annual growth rate of 0.81%.
IBM has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of IBM decreased in the last 3 years.
Dividend Growth(5Y)0.81%
Div Incr Years2
Div Non Decr Years2
IBM Yearly Dividends per shareIBM Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

78.75% of the earnings are spent on dividend by IBM. This is not a sustainable payout ratio.
IBM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP78.75%
EPS Next 2Y9.19%
EPS Next 3Y8.11%
IBM Yearly Income VS Free CF VS DividendIBM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B
IBM Dividend Payout.IBM Dividend Payout, showing the Payout Ratio.IBM Dividend Payout.PayoutRetained Earnings

INTL BUSINESS MACHINES CORP

NYSE:IBM (1/6/2026, 3:24:09 PM)

301.89

+6.92 (+2.35%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)01-28 2026-01-28/amc
Inst Owners64.18%
Inst Owner Change0%
Ins Owners0.09%
Ins Owner Change-1.55%
Market Cap282.19B
Revenue(TTM)65.40B
Net Income(TTM)7.91B
Analysts71.85
Price Target292.9 (-2.98%)
Short Float %2.12%
Short Ratio3.98
Dividend
Industry RankSector Rank
Dividend Yield 2.27%
Yearly Dividend6.68
Dividend Growth(5Y)0.81%
DP78.75%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.08%
Min EPS beat(2)4.89%
Max EPS beat(2)7.28%
EPS beat(4)4
Avg EPS beat(4)7.18%
Min EPS beat(4)3.59%
Max EPS beat(4)12.97%
EPS beat(8)8
Avg EPS beat(8)5.75%
EPS beat(12)11
Avg EPS beat(12)5.17%
EPS beat(16)15
Avg EPS beat(16)4.03%
Revenue beat(2)2
Avg Revenue beat(2)0.92%
Min Revenue beat(2)0.5%
Max Revenue beat(2)1.34%
Revenue beat(4)3
Avg Revenue beat(4)0.23%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.34%
Revenue beat(8)3
Avg Revenue beat(8)-0.35%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)8
Avg Revenue beat(16)0.23%
PT rev (1m)2.34%
PT rev (3m)4.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.41%
EPS NY rev (1m)0%
EPS NY rev (3m)2.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 27.52
Fwd PE 24.51
P/S 4.31
P/FCF 23.57
P/OCF 20.93
P/B 10.11
P/tB N/A
EV/EBITDA 20.9
EPS(TTM)10.97
EY3.63%
EPS(NY)12.32
Fwd EY4.08%
FCF(TTM)12.81
FCFY4.24%
OCF(TTM)14.42
OCFY4.78%
SpS69.97
BVpS29.85
TBVpS-54.8
PEG (NY)2.48
PEG (5Y)N/A
Graham Number85.84
Profitability
Industry RankSector Rank
ROA 5.4%
ROE 28.34%
ROCE 9.45%
ROIC 8.07%
ROICexc 9.31%
ROICexgc 52.18%
OM 16.06%
PM (TTM) 12.09%
GM 57.81%
FCFM 18.31%
ROA(3y)3.74%
ROA(5y)3.83%
ROE(3y)20.94%
ROE(5y)24.07%
ROIC(3y)7.07%
ROIC(5y)6.14%
ROICexc(3y)8.07%
ROICexc(5y)6.94%
ROICexgc(3y)39.64%
ROICexgc(5y)31.12%
ROCE(3y)8.28%
ROCE(5y)7.2%
ROICexgc growth 3Y23.43%
ROICexgc growth 5Y15.29%
ROICexc growth 3Y14.68%
ROICexc growth 5Y5.67%
OM growth 3Y10.6%
OM growth 5Y0.28%
PM growth 3Y-1.4%
PM growth 5Y-10.1%
GM growth 3Y1.05%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 1.98
Debt/FCF 5.27
Debt/EBITDA 3.6
Cap/Depr 31.23%
Cap/Sales 2.31%
Interest Coverage 250
Cash Conversion 87.87%
Profit Quality 151.41%
Current Ratio 0.93
Quick Ratio 0.89
Altman-Z 3.51
F-Score6
WACC8.83%
ROIC/WACC0.91
Cap/Depr(3y)39.45%
Cap/Depr(5y)41.95%
Cap/Sales(3y)2.96%
Cap/Sales(5y)3.91%
Profit Quality(3y)291.08%
Profit Quality(5y)263.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.71%
EPS 3Y1.19%
EPS 5Y-4.21%
EPS Q2Q%15.22%
EPS Next Y11.1%
EPS Next 2Y9.19%
EPS Next 3Y8.11%
EPS Next 5Y6.07%
Revenue 1Y (TTM)4.51%
Revenue growth 3Y3.05%
Revenue growth 5Y1.69%
Sales Q2Q%9.11%
Revenue Next Year6.83%
Revenue Next 2Y5.7%
Revenue Next 3Y5.23%
Revenue Next 5Y5.12%
EBIT growth 1Y14.74%
EBIT growth 3Y13.97%
EBIT growth 5Y1.98%
EBIT Next Year73.84%
EBIT Next 3Y24.02%
EBIT Next 5Y17.21%
FCF growth 1Y3.97%
FCF growth 3Y5.46%
FCF growth 5Y-0.17%
OCF growth 1Y0.37%
OCF growth 3Y1.67%
OCF growth 5Y-1.86%

INTL BUSINESS MACHINES CORP / IBM FAQ

What is the fundamental rating for IBM stock?

ChartMill assigns a fundamental rating of 4 / 10 to IBM.


What is the valuation status of INTL BUSINESS MACHINES CORP (IBM) stock?

ChartMill assigns a valuation rating of 2 / 10 to INTL BUSINESS MACHINES CORP (IBM). This can be considered as Overvalued.


How profitable is INTL BUSINESS MACHINES CORP (IBM) stock?

INTL BUSINESS MACHINES CORP (IBM) has a profitability rating of 7 / 10.


What are the PE and PB ratios of INTL BUSINESS MACHINES CORP (IBM) stock?

The Price/Earnings (PE) ratio for INTL BUSINESS MACHINES CORP (IBM) is 27.52 and the Price/Book (PB) ratio is 10.11.


Can you provide the financial health for IBM stock?

The financial health rating of INTL BUSINESS MACHINES CORP (IBM) is 2 / 10.